These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Osteoporosis: alternatives to estrogen treatment. Fitzpatrick LA Minn Med; 2003 Jan; 86(1):36-41. PubMed ID: 12585558 [TBL] [Abstract][Full Text] [Related]
26. [How to prevent early postmenopausal fracture risk? Proposition of a strategy]. Trémollieres F; Pouilles JM; Ribot C Gynecol Obstet Fertil; 2009 Jan; 37(1):50-6. PubMed ID: 19110461 [TBL] [Abstract][Full Text] [Related]
27. [Absolute risk for fracture and WHO guideline. Pharmacological intervention to prevent osteoporotic fractures in the elderly]. Hosoi T; Clin Calcium; 2007 Jul; 17(7):1098-104. PubMed ID: 17607078 [TBL] [Abstract][Full Text] [Related]
28. The role of menopausal hormone therapy in osteoporosis. de Villiers T Climacteric; 2007 Oct; 10 Suppl 2():71-3. PubMed ID: 17882677 [TBL] [Abstract][Full Text] [Related]
30. Justification for the use of HRT in the long-term prevention of osteoporosis. Stevenson JC Maturitas; 2005 Jun; 51(2):113-26. PubMed ID: 15917151 [TBL] [Abstract][Full Text] [Related]
31. Prevention and treatment of postmenopausal osteoporosis. Lewiecki EM Obstet Gynecol Clin North Am; 2008 Jun; 35(2):301-15, ix. PubMed ID: 18486843 [TBL] [Abstract][Full Text] [Related]
32. Treatment strategies for patients with low bone mass: the younger postmenopausal female. Honig S Bull NYU Hosp Jt Dis; 2008; 66(3):240-3. PubMed ID: 18937639 [TBL] [Abstract][Full Text] [Related]
33. Maintaining skeletal health among postmenopausal women. Ettinger B Am J Manag Care; 1998 Mar; 4(3):387-96. PubMed ID: 20919444 [TBL] [Abstract][Full Text] [Related]
34. Overview of bone mineral density in postmenopausal women. Notelovitz M J Reprod Med; 2002 Jan; 47(1 Suppl):71-81. PubMed ID: 11829080 [TBL] [Abstract][Full Text] [Related]
35. [Evidence for the selective estrogen receptor modulator raloxifene: its evolving role in the treatment of osteoporosis]. Ohta H Clin Calcium; 2008 Oct; 18(10):1442-50. PubMed ID: 18830041 [TBL] [Abstract][Full Text] [Related]
36. Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force. U.S. Preventive Services Task Force Ann Intern Med; 2005 May; 142(10):855-60. PubMed ID: 15897536 [TBL] [Abstract][Full Text] [Related]
37. The HRT misuse and osteoporosis epidemic: a possible future scenario. Gambacciani M; Ciaponi M; Genazzani AR Climacteric; 2007 Aug; 10(4):273-5. PubMed ID: 17653953 [TBL] [Abstract][Full Text] [Related]
38. [Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women--update 2009]. Dimai HP; Pietschmann P; Resch H; Preisinger E; Fahrleitner-Pammer A; Dobnig H; Klaushofer K; Wien Med Wochenschr Suppl; 2009; (122):1-34. PubMed ID: 19484202 [TBL] [Abstract][Full Text] [Related]
39. Trend in incidence of osteoporosis-related fractures among 40- to 69-year-old women: analysis of a large insurance claims database, 2000-2005. Islam S; Liu Q; Chines A; Helzner E Menopause; 2009; 16(1):77-83. PubMed ID: 18703983 [TBL] [Abstract][Full Text] [Related]